Last reviewed · How we verify
NCT05710445
Augmented Reality Heads-up Display to Improve Ultrasound Guided IV Access
NA trial testing Augmented Reality in Phlebotomy. Withdrawn.
1 March 2024
Quick facts
| Lead sponsor | University of Pennsylvania |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Start date | 16 February 2023 |
| Primary completion | 1 March 2024 |
| Estimated completion | 1 March 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Augmented Reality
Conditions studied
- Phlebotomy — all drugs for Phlebotomy →
Sponsor
University of Pennsylvania
Who can join
18 and older, any sex, with Phlebotomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to assess the utility of an augmented reality headset for visualization of ultrasound images during ultrasound guided placement of an intravenous catheter.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05710445
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Augmented Reality
Trials testing the same drug.
- NCT07112417 — "Augmented Reality-Assisted Miniscrew Placement in Orthodontics: A Clinical Trial" · NA · not yet recruiting
- NCT07113093 — The Effects of Augmented Reality Versus Virtual Reality · NA · recruiting
- NCT06761781 — Augmented Reality for Stroke Rehabilitation · NA · completed
- NCT05885334 — Caregivers Training Using Artificial Intelligence and Virtual Reality · NA · completed
- NCT06986655 — The Effect of an Augmented Reality Game on Pain, Fear, and Care Satisfaction Levels During Allergy Testing in Children A · NA · completed
Other recruiting trials for Phlebotomy
Currently open trials in the same condition.
- NCT05878483 — Autonomous Blood Drawing Optimization and Performance Testing · NA · recruiting
Other University of Pennsylvania trials
Trials by the same sponsor.
- NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
- NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
- NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
- NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
- NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05710445 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
- Last refreshed: 15 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05710445.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing